Search research articles
Contact Us
Filters
Showing results (281-290 of 394) with videos related to
Page
of 40
Sort By:
The New England Journal of Medicine
|
June 29, 1978
Effects of coronary-artery bypass on global and regional left ventricular function during exercise
K M Kent, J S Borer, M V Green, et al.
American Journal of Therapeutics
|
April 26, 2013
Cardiovascular safety of varenicline: patient-level meta-analysis of randomized, blinded, placebo-controlled trials
James H Ware, George W Vetrovec, Alan B Miller, et al.
British Heart Journal
|
May 1, 1985
Predictive value and limitations of the ST/HR slope
O Ameisen, P M Okin, R B Devereux, et al.
The American Journal of Cardiology
|
October 29, 2015
Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)
Michael Böhm, Michele Robertson, Ian Ford, et al.
Journal of Molecular and Cellular Cardiology
|
March 1, 1988
Hypertrophic and functional response to experimental chronic aortic regurgitation
N M Magid, M S Young, D C Wallerson, et al.
ESC Heart Failure
|
October 9, 2019
Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m
Nadia Bouabdallaoui, Eileen O'Meara, Virginie Bernier, et al.
European Journal of Heart Failure
|
February 8, 2014
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT
Adriaan A Voors, Dirk J van Veldhuisen, Michele Robertson, et al.
The American Journal of Cardiology
|
January 2, 2007
Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials
William B White, Christine R West, Jeffrey S Borer, et al.
Cardiology
|
January 9, 2009
Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts
Sharada L Truter, Daniel F Catanzaro, Phyllis G Supino, et al.
The American Journal of Cardiology
|
May 20, 2014
Risk of atrial fibrillation with use of oral and intravenous bisphosphonates
Abhishek Sharma, Andrew J Einstein, Ajay Vallakati, et al.
Page
of 40
Search research articles
Search
Showing results (281-290 of 394) with videos related to
Sort By:
Page
of 40
The New England Journal of Medicine
|
June 29, 1978
Effects of coronary-artery bypass on global and regional left ventricular function during exercise
K M Kent, J S Borer, M V Green, et al.
American Journal of Therapeutics
|
April 26, 2013
Cardiovascular safety of varenicline: patient-level meta-analysis of randomized, blinded, placebo-controlled trials
James H Ware, George W Vetrovec, Alan B Miller, et al.
British Heart Journal
|
May 1, 1985
Predictive value and limitations of the ST/HR slope
O Ameisen, P M Okin, R B Devereux, et al.
The American Journal of Cardiology
|
October 29, 2015
Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)
Michael Böhm, Michele Robertson, Ian Ford, et al.
Journal of Molecular and Cellular Cardiology
|
March 1, 1988
Hypertrophic and functional response to experimental chronic aortic regurgitation
N M Magid, M S Young, D C Wallerson, et al.
ESC Heart Failure
|
October 9, 2019
Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m
Nadia Bouabdallaoui, Eileen O'Meara, Virginie Bernier, et al.
European Journal of Heart Failure
|
February 8, 2014
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT
Adriaan A Voors, Dirk J van Veldhuisen, Michele Robertson, et al.
The American Journal of Cardiology
|
January 2, 2007
Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials
William B White, Christine R West, Jeffrey S Borer, et al.
Cardiology
|
January 9, 2009
Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts
Sharada L Truter, Daniel F Catanzaro, Phyllis G Supino, et al.
The American Journal of Cardiology
|
May 20, 2014
Risk of atrial fibrillation with use of oral and intravenous bisphosphonates
Abhishek Sharma, Andrew J Einstein, Ajay Vallakati, et al.
Page
of 40